GPIaIIa as a Candidate Target for Anti-platelet Autoantibody Occurrin during Valproate Therapy and Associated with Peroperative Bleeding

V. Proulle; P. Masnou; J. Cartron; C. Kaplan; N. Ajzenberg; G. Tchernia; M. Dreyfus

doi:10.1055/s-0037-1613778

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2000; 83(01): 175-176
DOI: 10.1055/s-0037-1613778

Letters to the Editor

Schattauer GmbH

GPIaIIa as a Candidate Target for Anti-platelet Autoantibody Occurrin during Valproate Therapy and Associated with Peroperative Bleeding

V. Proulle

¹From the Laboratoire d’Hématologie

,

P. Masnou

²Service de Neurologie, AP-HP, Faculté de Médecine Paris XI, CHU Bicêtre, Kremlin Bicêtre

,

J. Cartron

¹From the Laboratoire d’Hématologie

,

C. Kaplan

³Institut National de Transfusion Sanguine, Paris, France

,

N. Ajzenberg

¹From the Laboratoire d’Hématologie

,

G. Tchernia

¹From the Laboratoire d’Hématologie

,

M. Dreyfus

¹From the Laboratoire d’Hématologie

References
1 May R, Sunder TR. Hematologic manifestations of long-term valproate therapy. Epilepsia 1993; 34: 1098-101.
2 Gidal B, Spencer N, Maly M. Valproate mediated disturbances of hemostasis: relationship to dose and plasma concentration. Neurology 1994; 44: 1418-22.
3 Barr R, Copeland SA, Stockwell ML. Valproic acid and immune thrombocytopenia. Arch Dis Child 1982; 57: 681-4.
4 Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Haemost 1990; 16: 1-144.
5 De Catarina R, Lanza M, Manca G, Strata GB, Maffei S, Salvatore L. Bleeding time and bleeding:an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood 1994; 84: 3363-70.
6 Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991; 77: 2547-52.
7 Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987; 70: 1722-6.
8 Balduini C, Bertolino G, Noris P, Piovella F, Sinigaglia F, Bellotti V, Samaden A, Torti M, Mazzini G. Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa. Thromb Haemost 1992; 68: 208-13.
9 DiMinno G, Corragio F, Cerbone AM, Capitano AM, Manzo C, Spina M, Scarpato P, Dattoli GMR, Mattioli PL, Mancini M. A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder. J Clin Invest 1986; 77: 157-64.
10 Devine D, Currie MS, Rosse WF, Greenberg CS. Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib. Blood 1987; 70: 428-31.
11 Kubota T, Tanoue K, Murohashi I, Nara N, Yamamoto N, Yamazaki H, Aoki N. Autoantibody against platelet glycoprotein IIb-IIIa in a patient with non-Hodgkin’s lymphoma. Thromb Res 1989; 53: 379-86.
12 Meyer M, Kirchmaier CM, Schirmer A, Spangenberg P, Strohl C, Breddin K. Acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIb-IIIa complex-1:glycoprotein analysis. Thromb Haemost 1991; 65: 491-6.
13 Niessner H, Clemetson KJ, Panzer S, Mueller-Eckhardt C, Santoso S, Bettelheim P. Acquired thrombasthenia due to GPIIb-IIIa-specific platelet autoantibodies. Blood 1986; 68: 571-6.
14 Deckmyn H, Chew SL, Vermylen J. Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia:a novel cause of acquired qualitative platelet dysfunction. Thromb Haemost 1990; 64: 74-8.
15 Sixma JJ, van Zanten GH, Huizinga EG, van der Plas RM, Verkley M, Wu YP, Gros P, de Groot PG. Platelet adhesion to collagen:an update. Thromb Haemost 1997; 78: 434-8.
16 Dale B, Purdie GH, Rischbibth RH. Fibrinogen depletion with sodium valproate. Lancet 1978; 01: 1316-7.